The short version
- OCD use is off-label and experimental, with the smallest evidence base among the conditions on this page.
- Small controlled trials found some short-term obsessions reduction, but results have not replicated consistently.
- Standard, evidence-based OCD care — exposure and response prevention therapy with SSRIs — remains first-line.
- Higher ketamine doses used for depression may not translate to OCD benefit at all.
- Any clinic offering OCD ketamine treatment should describe it as investigational.
A small but interesting literature
Because ketamine rapidly affects glutamate signaling — and because glutamate abnormalities appear in OCD — researchers tested whether single infusions could reduce obsessions and compulsions. A few small double-blind trials found transient improvement in obsessions lasting days to about two weeks; others found no meaningful effect. The picture, as of the current literature, is unsettled.
Why expectations matter here
The depression evidence does not automatically transfer. OCD's response to ketamine, if real, appears weaker and shorter-lived, and the doses or schedules that might help are unknown. Any honest provider presents this treatment as investigational, not as a proven therapy.
What established OCD care looks like
Exposure and response prevention therapy remains the core treatment with the strongest evidence, often combined with SSRI medication at higher doses than depression requires. For treatment-resistant cases, FDA-cleared transcranial magnetic stimulation protocols and, rarely, deep brain stimulation exist within specialist care.
If you are considering ketamine for OCD anyway
Insist on medical screening, monitored dosing, standardized measurement of your symptoms, and a clear statement of what the evidence supports. Be wary of clinics selling large prepaid packages for an experimental use. If OCD coexists with crisis-level distress, call or text 988.
What a course of treatment looks like
- 1
Consultation and eligibility
A qualified healthcare professional reviews your diagnosis, treatment history, medicines, and safety risks before determining which treatment approach, if any, is appropriate.
- 2
Pricing, and coverage if it applies
IV, IM, and oral ketamine are off-label and usually self-pay, so ask for a written price for the full course. Only SPRAVATO® (esketamine) is commonly insurance-covered, typically after prior authorization.
- 3
A monitored treatment visit
Depending on the route, you receive an IV infusion, an IM injection, or a supervised oral dose — or, for SPRAVATO®, self-administer the nasal spray — while staff monitor your vital signs.
- 4
Recovery and a ride home
You rest until the effects wear off (at least two hours after SPRAVATO®). Arrange a ride home and do not drive until the next day after restful sleep.
- 5
Individualized follow-up
The prescriber assesses benefit, tolerability, and ongoing need, including whether maintenance sessions make sense for you.
Eligibility
Could ketamine treatment be an option to discuss?
A clinic confirms all of this at your consultation. Use it to see whether a consultation is worth booking.
- A confirmed OCD diagnosis by a qualified clinician
- Inadequate response to first-line treatment (ERP therapy and/or SSRIs)
- Cardiovascular and psychiatric screening completed
- No current psychosis or unstable substance use disorder
- Clear understanding that evidence is preliminary and costs are out of pocket
Questions people ask
Does ketamine work for OCD?
The evidence is genuinely mixed. Some small controlled trials reported rapid reductions in obsessive thoughts lasting days to a week or two; others found no significant benefit. No large replication trial has settled the question.
Why is it considered experimental for OCD?
No FDA approval, small and inconsistent trials, no established dosing protocol, and uncertainty about whether the antidepressant mechanism extends to obsessions all place OCD ketamine use in the experimental category.
What should standard OCD treatment be?
Exposure and response prevention (ERP), a form of cognitive behavioral therapy, together with high-dose SSRIs, has the strongest evidence. Newer options like transcranial magnetic stimulation are also FDA-cleared for OCD.
If I try it anyway, what should I insist on?
A clinician who names the evidence limits plainly, medical screening before dosing, monitored sessions, standardized symptom measurement, and no pressure into long prepaid packages — which no credible provider should sell for an experimental use.
Other conditions we cover
Treatment-resistant depression
Depression that has not responded adequately to at least two oral antidepressants. Esketamine nasal spray (SPRAVATO®) is FDA-approved for this use in adults; IV, IM, and oral ketamine are off-label options that many clinics offer.
Depression (major depressive disorder)
Ketamine-based treatments act on glutamate, a different pathway from traditional antidepressants, and can work within hours to days for some patients. Only esketamine is FDA-approved, and only for specific depression populations; other routes are off-label.
Anxiety disorders
Early evidence from randomized trials and meta-analyses suggests ketamine can reduce anxiety symptoms short-term, including in people whose anxiety has resisted other treatments. All such use is off-label — no ketamine-based medicine is FDA-approved for anxiety.
PTSD
Ketamine is being studied and used off-label for post-traumatic stress disorder, with early trials suggesting rapid but temporary symptom reduction. Esketamine is not approved for PTSD, and treatment should be coordinated with trauma-focused therapy.
Chronic pain
Ketamine is an FDA-approved anesthetic, but its use for chronic pain conditions — neuropathic pain, complex regional pain syndrome, fibromyalgia — is off-label. Evidence is mixed, with some support for neuropathic and CRPS pain.
Ketamine treatment centers near you
Browse clinics by town or county, or read more about treatment in United States.
This guide is general information, not medical advice. Only a prescriber who knows your history can say whether ketamine treatment, including SPRAVATO® (esketamine), is right for you. If you are in crisis, call or text 988.